Medical Cannabis in the Workplace: an Employer’s Guide to Testing, Safety and Rights
As more people in the UK access prescribed cannabis-based medicines, employers are facing questions around drug testing, workplace safety and employee rights.
Explainers and foundations for understanding cannabis medicine from the ground up.
As more people in the UK access prescribed cannabis-based medicines, employers are facing questions around drug testing, workplace safety and employee rights.
Could medical cannabis help with MS, Parkinson’s, epilepsy or nerve pain? We explore what the research shows and where questions remain…
Endometriosis affects an estimated 190 million people worldwide, and gaps in care are leading to an increased interest in cannabis-based medicines. What do we know about how these might help, and does the science support it?
Online services have made medical cannabis easier to get hold of in Germany – but are patients getting the medical checks they need? Would tighter rules make prescribing safer or just leave patients struggling to find a doctor and get their medicine? Cannabis Health explores the debate…
More women are exploring medical cannabis to manage symptoms such as sleep disturbances, anxiety, and chronic pain during the menopause.
The endocannabinoid system (ECS) plays an important role in bodily function. Here, we unpack the science that is often missing from medical school curricula.
The association between cannabis and psychosis is among the most studied — and most contested — areas of cannabinoid medicine.
What is actually legal when it comes to medical cannabis in the UK? From prescriptions and possession to driving, smoking and NHS access, here’s what patients need to know about the law in 2026.
How do medical cannabis vaporisers work, what are the different types, and what should UK patients know about using them safely?
Anxiety is one of the most common conditions for which medical cannabis is prescribed in the UK, but the evidence base remains mixed.
Could cannabinoids offer an alternative to opioids for people living with chronic pain – and what does the evidence actually show?
Medical cannabis costs can vary quite significantly in the UK depending on the provider, prescribed medication and clinic fees.
Where legitimate risk management tips over into discrimination against a lawfully treated employee, and how to tell the difference.
Upcoming Symposium
Evidence-led education for clinicians, industry and patient advocates — across Europe.
Every ticket includes 12 months’ free MCCS membership — worth up to £120.
26 November 2026
London · Conway Hall